Loading…
20,252 grants found
Showing 1,941 – 1,960 of 20,252 grants
Project Summary/Abstract Synthetic lethality screens hold great promise for cancer therapy since they enable the identification of chemical compounds that selectively target tumor...
PROJECT SUMMARY Lung cancer is a leading cause of cancer death in the United States, with non-small cell lung cancer (NSCLC) being the major subtype accounting for approximately 85...
PROJECT SUMMARY/ABSTRACT Lung cancer is the second deadliest cancer. Despite its prevalence and unfavorable consequences, current therapeutic approaches are limited. The proposed s...
ABSTRACT Randomized controlled trials (RCTs) are the gold standard for assessing interventions for preventing and treating cancer, but their external validity is only guaranteed if...
PROJECT SUMMARY Focused Ultrasound (FUS) is a powerful technology now FDA approved for several ablative brain therapies, and has demonstrated an impressive safety and efficacy prof...
SUMMARY/ABSTRACT Relapsed pediatric T-cell acute lymphoblastic leukemia (T-ALL) is often refractory to conventional therapy and is associated with a dismal survival rate of less th...
PROJECT SUMMARY E-cigarette use (vaping) in 18-24-year-olds is a public health crisis. It is an urgent public health priority to communicate to young adults about the health harm o...
ABSTRACT Breast cancer (BC) is a complex and heterogeneous neoplastic disease with a high incidence and mortality. BC can be divided into clinical, histopathologic, and molecular s...
SUMMARY Esophageal adenocarcinoma (EAC) is the most prevalent histological type of esophageal malignancy in the US and many Western nations. This tumor remains deadly as approximat...
ABSTRACT T-cell large granular lymphocytic leukemia (T-LGLL) is an incurable, underdiagnosed proliferation of clonal CD8+ cytotoxic T-lymphocytes that results in severe neutropenia...
Combining immune checkpoint inhibitors with BRAF and MEK inhibitors has enabled significant improvements in treating metastatic skin cutaneous melanomas that possess activating mut...
Project Summary. Cancer is governed by evolutionary principles whereby sequential changes at the genetic and epigenetic level enable proliferation, immune evasion, drug resistance,...
PROJECT SUMMARY/ABSTRACT Even the largest lung cancer screening trial to date, the National Lung Cancer Screening Trial (NLST) is insufficient on its own to answer questions about...
PROJECT SUMMARY Germline pathogenic mutations and common variants have been implicated in the development of clear cell renal cell carcinoma (ccRCC). Similarly, recurrent somatic a...
PROJECT SUMMARY There is a critical need for treatment approaches that conveniently deliver evidence-based interventions of counseling and pharmacotherapy to a wide range of smoker...
Peripheral T-cell lymphomas (PTCL), derived from mature T cells, are aggressive malignancies for which existing therapies are suboptimal, as the median overall survival of patients...
PROJECT SUMMARY While cancer cachexia is a devastating syndrome characterized by progressive muscle wasting, inflammation, and metabolic disruption, the underlying mechanisms remai...
PROJECT SUMMARY/ABSTRACT Small cell lung cancer (SCLC) is an extremely deadly cancer, and current chemo/radiation therapies lack durable effects. Immunotherapy with immune checkpoi...
PROJECT SUMMARY Oncoproteins drive tumor development and aggressive growth by dysregulating the signaling pathways involved in cell growth, survival, and proliferation. Targeting o...
Project Summary We have identified a novel mode of autonomous programmed cell death that is controlled by p53 in small cell lung cancer (SCLC) — the most deadly form of lung cancer...